Purpose

We will be directly comparing a high-quality protein diet composed primarily of lean pork loin (PORK) to a lower-quality plant-based protein diet (PLANT) in individuals with prediabetes on muscle and whole-body protein turnover and glucose regulation.

Conditions

Eligibility

Eligible Ages
Between 40 Years and 65 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 1. Males and females ages 40-65 years. - 2. BMI 25 to ≤40 kg/m2 (or body fat % ≥25% in males or ≥36% in females) - 3. Capable of providing informed consent. - 4. COVID-19 negative and/or asymptomatic. - 5. Willing to abstain from drinking alcohol or consuming marijuana and CBD products during the 4-day study meal period - 6. HbA1c: 5.7-6.4% or fasting glucose 100-125 mg/dL

Exclusion Criteria

  • 1. Participant who does not/will not eat animal protein sources. - 2. Allergy to wheat, soy, or common ingredients in plant-based protein products. - 3. Body mass index <25 kg/m2 or >40 kg/m2. - 4. Hemoglobin <10g/dL at screening. - 5. Platelets <150,000/uL at screening. - 6. History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment. - 7. History of gastrointestinal bypass/reduction surgery. - 8. Pregnant or lactating individuals. - 9. History of a chronic inflammatory disease (e.g. Lupus, Crohn's disease) - 10. Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy. - 11. Currently using prescription blood thinning medications. - 12. Currently using corticosteroid medications (cortisone, hydrocortisone, prednisone, etc.). - 13. Unable or unwilling to suspend aspirin use for 7 days prior to Visit 3 and Visit 7. - 14. Unwilling to avoid using protein or amino-acid supplements during participation. - 15. Unwilling to fast overnight. - 16. Unwilling to avoid alcohol, marijuana and CBD products for the four study days. - 17. Participants on glucagon-like-peptide-1 receptor agonist (GLP-1-RA) medications for <1 month or with less than one treatment dose (injection) every two weeks

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
High Quality Protein Intake - Lean Pork
Meal patterns will mimic a standard American diet (50% carbohydrate, 15% protein, 35% fat), providing an isonitrogenous 0.8 g/kg/d protein, and meeting individual estimated daily energy requirements. We have chosen 0.8 g/kg/d as it is the recommend dietary allowance for protein in the US. This arm's protein source will be from lean pork.
  • Other: Lean Pork vs Plant-Based Protein
    Participants will eat prepared study meals for three days that have either protein sourced from lean pork or plant-based sources.
Active Comparator
Low Quality Protein Intake - Plant-Based
Meal patterns will mimic a standard American diet (50% carbohydrate, 15% protein, 35% fat), providing an isonitrogenous 0.8 g/kg/d protein, and meeting individual estimated daily energy requirements. We have chosen 0.8 g/kg/d as it is the recommend dietary allowance for protein in the US. This arm's protein source will be from plant-based protein (ie impossible burger, black bean burger, soy, etc).
  • Other: Lean Pork vs Plant-Based Protein
    Participants will eat prepared study meals for three days that have either protein sourced from lean pork or plant-based sources.

Recruiting Locations

University of Arkansas for Medical Sciences
Little Rock, Arkansas 72205
Contact:
David D Church, PhD
dchurch@uams.edu

More Details

NCT ID
NCT06025292
Status
Recruiting
Sponsor
University of Arkansas

Study Contact

David Church, PhD
501-526-5769
dchurch@uams.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.